Dosage forms
US6221394A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Jan 5, 2000 |
| Grant date | Apr 24, 2001 |
| Priority date | — |
| Expiry date | Jan 5, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2054
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical dosage form comprises, in one portion thereof, a substantially single (+)-enantiomer of a chiral drug other than verapamil and, in another, separate portion thereof, a substantially single (-)-enantiomer of the drug wherein, in use, the different enantiomers are released at different rates from the dosage form. The dosage form is useful for administration of chiral drugs where both enantiomers have a valid pharmacological input, and where a clinical benefit may be realised by controlling the release rates of those enantiomers. Examples of such drugs include, in particular, tramadol and warfarin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.